ESR1 and breast cancer: Proposed mechanisms for the origin of ER− breast cancers include that of pressures being exerted on ER+ cells by oestrogen withdrawal, hypoxia, or overexpression of epidermal growth factor receptor or ErbB2 resulting in MAPK hyperactivation (Creighton et al, 2006).